AzTrials
AzTrials

FunctionNCT06937879

Investigation of Factors Affecting Upper Extremity Function in Healthy Young Adults

An observational study of Function, run by KTO Karatay University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to determine the effects of grip strength, motor imagery and two-point discrimination on upper extremity function in healthy young adults. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Function
What is being tested?
Hand Grip Strength
How many people
99 participants
Where
1 siteTurkey (Türkiye)
Study dates
21 Apr 2025to 12 May 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Healthy young adults

Who may be able to join

  • Being a university student,
  • Being between the ages of 18-35
  • Not having any known upper extremity problems

Who cannot join

  • Upper extremity surgery history
  • Neurological problems
  • Chronic diseases

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • KTO Karatay University

    Karatay, Konya, 42020

Other trials in Turkey (Türkiye)

About this study

The aim of this study was to determine the effects of grip strength, motor imagery and two-point discrimination on upper extremity function in healthy young adults.

Conditions
Function
Being tested
Hand Grip Strength

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hand Grip StrengthOther

    The grip strength of the participants will be performed with a hydraulic hand dynamometer on a chair with back and arm support. The participant will be asked to squeeze the dynamometer with maximum force. The measurement will be performed 3 times and the average value will be recorded.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Function

    The Turkish version of the Shoulder, Arm and Hand Problems Questionnaire (DASH-T) will be used to assess the functional level of the upper extremity [10]. The DASH-T questionnaire consists of 30 questions. The first 20 questions ask about physical ability and the last 10 questions ask about pain and related functional and environmental limitations. As the score approaches zero, the functional level of the person is high; as the score moves away from zero, the functional level of the person is low.

    Measured: Baseline

Secondary outcomes (3)
  1. Grip strength

    The grip strength of the participants will be performed with a hydraulic hand dynamometer on a chair with back and arm support. The participant will be asked to squeeze the dynamometer with maximum force. The measurement will be performed 3 times and the average value will be recorded.

    Measured: Baseline

  2. Motor imagery

    Motor imagery will be assessed through a left/right judgment task in which participants will be required to recognize whether hand images correspond to their left or right side using the Recognise™ application (Neuro Orthopaedic Institute, Adelaide, Australia). For this test, participants will be seated comfortably in front of a table, with both elbows flexed at 90◦ and both index fingers placed at the bottom of the screen of an electronic tablet. Multiple images of forearms (20 on each side) in multiple postures, angles and skin colors will be randomly displayed in the center of the screen of the device. Participants will be given standard instructions to decide as quickly and accurately as possible whether each image is of the right or left hand by clicking on the 'left' (left fingers) or 'right' (right fingers) buttons displayed at the bottom of the screen.

    Measured: Baseline

  3. Two-point discrimination

    Two-point discrimination will be assessed using a two-dot discriminator placed longitudinally and perpendicular to the index fingertip. The test score is the minimum distance at which the participant can discriminate between two dots in five consecutive trials. The assessment starts with a distance of 4 mm and is gradually reduced or increased depending on the participant's performance. A distance greater than 4 mm is considered impaired

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2025
  2. Study start21 Apr 2025
  3. Primary completion12 May 2025
  4. Study completion12 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06937879
Sponsor's protocol ID
KaratayUH14
Status last verified
May 2025
First submitted
14 Apr 2025
Last updated
15 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Function, run by KTO Karatay University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Function (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in